| Cancer site | Sex | Relative risk (95% CI)† |
|---|---|---|
| Esophagus | Men | 1.52 (1.33-1.74) |
| Women | 1.51 (1.31-1.74) | |
| Pancreas | Men | 1.07 (0.93-1.23) |
| Women | 1.12 (1.02-1.22) | |
| Colorectum | Men | 1.24 (1.20-1.28) |
| Women | 1.09 (1.05-1.13) | |
| Kidney | Men | 1.24 (1.15-1.34) |
| Women | 1.34 (1.25-1.43) | |
| Gall bladder | Men | 1.09 (0.99-1.21) |
| Women | 1.59 (1.02-2.47) | |
| Breast | Women | 1.12 (1.08-1.16) |
| Endometrium | Women | 1.59 (1.50-1.68) |
Note: CI = confidence interval.
*Risk estimates from Renehan and colleagues:12 meta-analysis of 76 studies including 67 cohort studies, 6 nested case-control studies and 3 randomized trials (with a total of 282 137 incident cancer cases reported) published between 1966 and 2007.
†Risk estimates are for an increase in body mass index of 5 kg/m2.